Insight into the structure, function, and biosynthesis of factor VIII through recombinant DNA technology.

作者信息

Kaufman R J

机构信息

Genetics Institute, Cambridge, MA 02140.

出版信息

Ann Hematol. 1991 Sep;63(3):155-65. doi: 10.1007/BF01703248.

DOI:10.1007/BF01703248

PMID:1932292

Abstract

摘要

相似文献

Insight into the structure, function, and biosynthesis of factor VIII through recombinant DNA technology.

Ann Hematol. 1991 Sep;63(3):155-65. doi: 10.1007/BF01703248.

Expression and structure-function properties of recombinant factor VIII.

Transfus Med Rev. 1992 Oct;6(4):235-46. doi: 10.1016/s0887-7963(92)70174-6.

Biotechnology and the plasma fractionation industry--the impact of advances in the production of coagulation factor VIII.

Australas Biotechnol. 1993 Jan-Feb;3(1):16-20.

The manufacture of factor VIII concentrates.

Transfusion. 1991 Jul-Aug;31(6):573-4. doi: 10.1046/j.1537-2995.1991.31691306259.x.

The protein structure and effect of factor VIII.

Thromb Res. 2007;119(1):1-13. doi: 10.1016/j.thromres.2005.12.015. Epub 2006 Feb 17.

Structure and function of Factor VIII.

Adv Exp Med Biol. 1995;386:3-17. doi: 10.1007/978-1-4613-0331-2_1.

rFactor VIII deficit questioned.

Nat Biotechnol. 2000 Nov;18(11):1133. doi: 10.1038/81098.

Factor VIII structure and function.

Thromb Haemost. 1993 Jul 1;70(1):63-7.

The life cycle of coagulation factor VIII in view of its structure and function.

Blood. 1998 Dec 1;92(11):3983-96.

SK-HEP cells and lentiviral vector for production of human recombinant factor VIII.

Biotechnol Lett. 2012 Aug;34(8):1435-43. doi: 10.1007/s10529-012-0925-4. Epub 2012 Apr 10.

引用本文的文献

Inhibitor questions: plasma-derived factor VIII and recombinant factor VIII.

Ann Hematol. 1994;68 Suppl 3:S29-34. doi: 10.1007/BF01774527.

本文引用的文献

HEMOPHILIA. II. SOME PROPERTIES OF A SUBSTANCE OBTAINED FROM NORMAL HUMAN PLASMA EFFECTIVE IN ACCELERATING THE COAGULATION OF HEMOPHILIC BLOOD.

J Clin Invest. 1937 Jan;16(1):113-24. doi: 10.1172/JCI100829.

Antihemophilic globulin assay following plasma infusions in hemophilia.

J Lab Clin Med. 1958 Jun;51(6):850-9.

Coordinate binding of factor Va and factor Xa to the unstimulated platelet.

J Biol Chem. 1981 Jan 25;256(2):743-51.

Factor Va-dependent binding of factor Xa to human platelets.

J Biol Chem. 1980 Feb 10;255(3):1170-4.

Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets.

Eur J Biochem. 1982 Feb;122(2):429-36. doi: 10.1111/j.1432-1033.1982.tb05898.x.

Protein C deficiency in a Dutch family with thrombotic disease.

Thromb Haemost. 1982 Aug 24;48(1):1-5.

Deficiency of protein C in congenital thrombotic disease.

J Clin Invest. 1981 Nov;68(5):1370-3. doi: 10.1172/jci110385.

Response to infusions of polyelectrolyte fractionated human factor VIII concentrate in human haemophilia A and von Willebrand's disease.

Br J Haematol. 1982 Oct;52(2):259-67. doi: 10.1111/j.1365-2141.1982.tb03888.x.

A canine model of hemophilic (factor VIII:C deficiency) bleeding.

Blood. 1982 Sep;60(3):727-30.

Characterization of the human factor VIII procoagulant protein with a heterologous precipitating antibody.

Proc Natl Acad Sci U S A. 1982 Mar;79(5):1648-52. doi: 10.1073/pnas.79.5.1648.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验